StratGraph
Companies / Financials
SCHW

Charles Schwab Corporation

Investment Banking & Brokerage

Investment Banking & BrokerageAnalysis in progress
In progress

We are decoding this company's strategy and relationships

New analyses are published every weekday. Founding members get them first.

Business at a glance

Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work

Operating health86
Growth71
Profitability100
Cash generationn/a
Balance sheetn/a
Dilution control87
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)16.9%Revenue growth (FY)22.0%Revenue CAGR (3y)4.8%Gross margin—Operating margin—Net margin37.0%Free cash flow margin36.6%R&D / revenue—Stock comp / revenue1.3%Net debt / operating cash flow-2.36xCurrent ratio—Diluted share count change-1.4%
Fiscal year endingFY 2021-12FY 2022-12FY 2023-12FY 2024-12FY 2025-12
Revenue$18.5B$20.8B$18.8B$19.6B$23.9B
Net income$5.9B$7.2B$5.1B$5.9B$8.9B
Operating cash flow$2.1B$2.1B$19.6B$2.7B$9.3B
Capital expenditure$916M$971M$700M$620M$548M
Free cash flow$1.2B$1.1B$18.9B$2.0B$8.8B
Stock-based comp$254M$366M$320M$337M$317M
Buybacks$0$3.4B$2.8B$0$7.3B
Dividends$1.8B$2.1B$2.3B$2.3B$2.3B
Cash$63.0B$40.2B$43.3B$42.1B$46.0B
Total debt$23.8B$37.9B$26.1B$22.4B$24.1B
Equity$56.3B$36.6B$41.0B$48.4B$49.4B

StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.